A number of expressed proteins in the cancerous group (OM in all stages and OSCC) were found in protein–chemotherapy drug interactions (cisplatin and doxorubicin) including PTPN1, BRCA2, WBP2, P2Y1 and PSME4 (Figs 7–9). The gene discussed is P2RY1; the disease is ocular melanoma.